Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $17.20.
Several equities analysts have weighed in on the company. Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, September 17th. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a research report on Saturday, August 8th. Finally, Mizuho dropped their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 15th.
Check Out Our Latest Stock Analysis on SENS
Insider Transactions at Senseonics Holdings, Inc. Common Stock
In other news, Director Douglas Roeder bought 13,953 shares of the stock in a transaction on Wednesday, August 19th. The shares were purchased at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the purchase, the director directly owned 171,191 shares of the company's stock, valued at $1,537,295.18. This trade represents a 8.87% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.70% of the company's stock.
Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock
Institutional investors have recently made changes to their positions in the company. Integrated Wealth Concepts LLC acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $36,000. Readystate Asset Management LP acquired a new position in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $574,000. Penn Capital Management Company LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at $535,000. Stonepine Capital Management LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at $276,502. Finally, Jefferies Financial Group Inc. bought a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter worth $102,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.
Senseonics Holdings, Inc. Common Stock Trading Up 1.2%
NASDAQ SENS opened at $10.17 on Thursday. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $11.58. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74. The stock has a market cap of $425.11 million, a price-to-earnings ratio of -4.56 and a beta of 1.08. The firm's 50 day moving average price is $8.24 and its two-hundred day moving average price is $6.95.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.08). The business had revenue of $14.48 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. Equities analysts anticipate that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current year.
About Senseonics Holdings, Inc. Common Stock
(
Get Free Report)
Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes. Its technology is designed to measure glucose levels continuously and provide readings through a wearable transmitter and mobile application, supporting diabetes management and treatment decisions.
The company's principal product is the Eversense CGM system, which uses a small sensor implanted under the skin, a removable smart transmitter worn over the sensor, and a smartphone application.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Senseonics Holdings, Inc. Common Stock, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Senseonics Holdings, Inc. Common Stock wasn't on the list.
While Senseonics Holdings, Inc. Common Stock currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.